Third Harmonic Bio, Inc.
A clinical-stage biopharmaceutical company working to develop potent, selective, oral KIT inhibitors for the treatment of allergic and inflammatory diseases. The company is developing oral small molecule inhibitors to treat inflammatory diseases such as urticaria that are mediated by mast cells present in connective and vascular tissues throughout the body. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 31 |
Founded | 2019 |
Financials | |
|---|---|
Market Capitalization | 531.52M |
Revenue | |
Operating Income | -43.26M |
Operating Margin | |
Net Income | -29.59M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4376 / 5373 |
Sector : Healthcare | 686 / 1144 |
Industry : Biotechnology | 308 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2942 / 5565 |
Sector : Healthcare | 432 / 1182 |
Industry : Biotechnology | 204 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4039 / 5436 |
Sector : Healthcare | 574 / 1164 |
Industry : Biotechnology | 247 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4644 / 5330 |
Sector : Healthcare | 884 / 1174 |
Industry : Biotechnology | 436 / 667 |